April 28, 2020

PERT Consortium Announces COVID-19 PE Registry

April 28, 2020—The Pulmonary Embolism Response Team (PERT) Consortium announced the new PERT COVID-19 PE Registry, which is intended to be a de-identified, observational registry within an existing large multi-institutional database dedicated to the study of patients with pulmonary embolism (PE) to capture the clinical characteristics and outcomes of patients with confirmed COVID-19 and PE.

Participation in the COVID-19 PE Registry is free and database membership will be waived for the next year. Information on joining the registry is available online.

According to the PERT Consortium, there is a lack of information regarding the epidemiology, clinical features, and outcomes of patients with concurrent COVID-19 and PE; therefore, the registry seeks to address the urgent need to rapidly collect and disseminate information about patients with both COVID-19 and PE, given that both conditions carry high rates of morbidity and mortality.

PERT will leverage the infrastructure of the existing registry, which uses the user-friendly and rapidly scalable REDCap Cloud platform, both to collect the necessary information for the COVID-19 and PE registry and to quickly scale it up to meet the needs of this rapidly growing disease. A major benefit of this registry is the ability to use historic data from the existing PE registry as a control group.

The COVID-19 PE Registry will provide expedient public reporting of aggregate data on the clinical characteristics and outcomes of patients with COVID-19 and PE in order to facilitate clinical decision-making and allocate resources.

According to the announcement, PERT Consortium is the only collaborative group that can examine this invaluable information on a large scale, in detail, and have a comparative arm. In addition, because of its size and infrastructure, PERT Consortium has the ability to collect, analyze, and deliver this information in a timely manner.

“The PERT Consortium was formed to improve the outcomes of all patients with PE through team-based care," Robert Lookstein, MD, President-Elect of the PERT Consortium, commented to Endovascular Today. "Our organization is deeply concerned about the growing incidence of venous thromboembolism reported in COVD-19 patients. We are excited about this unique opportunity to identify how and when these patients are at risk and, most importantly, how we can collectively identify diagnostic and therapeutic interventions to help patients around the world.”


April 28, 2020

IceCure Continues Global Expansion of ProSense Cryoablation System With Approval in India

April 27, 2020

SCAI Confirms Dates for 2020 Virtual Conference